Lazard Asset Management
QTTB icon

Lazard Asset Management’s Q32 Bio QTTB Stock Holding History

Lazard Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-492
Closed -$8K – 2574
2023
Q1 		$8K Buy
492
+88
+22% +$2.19K ﹤0.01% 2147
2022
Q4 		$8K Sell
404
-112
-22% -$2.97K ﹤0.01% 2224
2022
Q3 		$14K Buy
516
+4
+0.8% +$163 ﹤0.01% 2130
2022
Q2 		$17K Buy
512
+17
+3% +$580 ﹤0.01% 2154
2022
Q1 		$26K Buy
495
+138
+39% +$8.57K ﹤0.01% 2017
2021
Q4 		$22K Buy
357
+62
+21% +$6.02K ﹤0.01% 2034
2021
Q3 		$41K Sell
295
-720
-71% -$91.7K ﹤0.01% 1780
2021
Q2 		$131K Buy
1,015
+1,006
+11,178% +$126K ﹤0.01% 1283
2021
Q1 		$1K Hold
9
– – ﹤0.01% 1829
2020
Q4 		$1K Buy
+9
New +$1.74K ﹤0.01% 1823

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lazard Asset Management's QTTB Position: Q2 2023 in Review

Lazard Asset Management sold out of Q32 Bio (QTTB) in Q2 2023, closing a stake of 492 shares — an estimated $8K sold.

Lazard Asset Management first reported a position in QTTB in Q4 2020 and held it in 10 quarters. The position peaked at $131K in Q2 2021. 59 funds tracked by Wall St. Rank hold QTTB as of Q2 2023.

  • Lazard Asset Management reported no remaining Q32 Bio position as of Q2 2023 after selling out during the quarter.
  • Lazard Asset Management sold 492 Q32 Bio shares in Q2 2023, an estimated $8K.
  • Lazard Asset Management first reported a position in Q32 Bio in Q4 2020 and held it in 10 quarters.
  • Lazard Asset Management's Q32 Bio position peaked at $131K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2023.

Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.